Cannvas Team Take Over Two Booths at Web Summit 2018
Exhibits Demonstrate Importance of Data in Emerging Global Cannabis Sector
TORONTO, Oct. 24, 2018 /CNW/ – Cannvas MedTech Inc. (“Cannvas” or the “Company”) (CSE: MTEC) (Frankfurt: 3CM), a leading business technology company in the cannabis space, is pleased to announce its senior team will travel to Lisbon to attend the 2018 Web Summit, Europe’s largest and most important technology marketplace. In addition to high-level networking with leading investors and CEOs from around the world, Cannvas will also present two booths related to their Cannvas.Me and Cannvas.Pet platforms, compete in pitch presentations and participate in mentoring sessions. This year’s Web Summit takes place November 5-6 at the Altice Arena in Portugal’s capital city.
PITCH is a startup competition at Web Summit open to any exhibiting startup that has received under €3 million (approx. $4.4 million CND) in funding to date. Cannvas MedTech will be one of 160 startups to present in front of distinguished investor panels, influential media and thousands of attendees as competitors look to secure funding and guidance from leading investors across the globe. The leadership team at Cannvas will also attend several mentoring sessions, a series of pre-scheduled, 15-minute meetings between high-level attendees and startups during which speakers, investors, partners and media give business advice to startups.
Cannvas will present two exhibits for attendees to learn more about their platforms Cannvas.Me and Cannvas.Pet. Cannvas.Me is a free unbiased educational resource for medicinal and adult-use cannabis users offering a comprehensive solution for the global cannabis community with physician-backed content and innovative tools for all audiences wishing to learn about health care through cannabis. Through technology and machine learning, Cannvas.Pet aims to become the online authority for pet owners to educate, track and improve the overall treatment of their furry loved ones.
“We have had the privilege of attending world-class technology conferences with considerable support from our friends at Tech West Canada and have leveraged this support to explore real opportunities and significantly grow our business,” said Steve Loutskou, Chief Operating Officer of Cannvas MedTech Inc. “Tech West is known to provide early-stage tech companies like Cannvas with incredible strategic guidance and business development support at an international level, and they have been a valuable partner in helping introduce our patient-centric medical cannabis platform.”
Over the past year, Cannvas has been part of important delegations from Canada that were showcased by Tech West at three international trade events: Web Summit in Lisbon, Portugal, CES in Los Angeles, California and Mobile World Congress in Barcelona, Spain. On an annual basis Tech West promotes a team of innovative tech companies making a global impact at conferences around the world under a unified Canada brand.
About Web Summit
Web Summit has become “Europe’s largest and most important technology marketplace” – an unrivalled gathering of the world’s most disruptive technology companies and those harnessing their innovation to transform their businesses and their lives. World-class speakers, leading investors, and international media will come together for the ultimate startup gathering. Not to mention the CEOs of some of the most exciting companies and startups in the world. For more information, please visit www.websummit.com.
About Tech West Canada
Tech West Canada is funded by Western Economic Diversification Canada and is a flagship project of the ICT Association of Manitoba (ICTAM). By working in collaboration with the governments of Alberta, British Columbia, Manitoba and Saskatchewan, we are helping western Canadian technology companies go global. For more information: www.techwestcanada.ca.
About Cannvas MedTech Inc.
Cannvas MedTech is a leading business technology company in the cannabis space. We design and build customer-centric solutions that enable our partners to harness the power of data to truly understand their customers, industry, and key business drivers.
No stock exchange or securities regulatory authority has reviewed or accepted responsibility for the adequacy or accuracy of this release.
Some of the statements contained in this release are forward-looking statements, such as estimates and statements that describe the Issuer’s future plans, objectives or goals, including words to the effect that the Issuer or management expects a stated condition or result to occur. Since forward-looking statements address future events and conditions, by their very nature, they involve inherent risks and uncertainties. For a description of the risks and uncertainties facing the Company and its business and affairs, readers should refer to the Company’s Management’s Discussion and Analysis and other disclosure filings with Canadian securities regulators, which are posted on www.sedar.com.
SOURCE Cannvas MedTech Inc.
For further information: www.cannvasmedtech.com; Media Inquiries, email@example.com; Investor Relations, firstname.lastname@example.org, 1-800-489-0116